Prognosis is overall excellent with intraductal papilloma. InÂ one particular study, 88.9% of the intraductal papillomas were found to be without atypia, while 9.2% showed atypia. The upgrade rate on pathology was low, found to be 7.3%: 1.3% for invasive cancer, 2.7% for DCIS, and 3.3% for atypical ductal hyperplasia.